LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP6 | 0.5678 | 0.0182 | 0.2794 | 0.0522 |
| SK-BR-3 | Dovitinib | 3.33 | uM | LJP5 | 0.5506 | 0.0374 | 0.2580 | 0.0269 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 1.0732 | 0.0186 | 1.1192 | 0.0278 |
| SK-BR-3 | Erlotinib | 3.33 | uM | LJP5 | 0.9250 | 0.0402 | 0.8821 | 0.0638 |
| SK-BR-3 | Foretinib | 3.33 | uM | LJP5 | 0.3782 | 0.0133 | -0.0344 | 0.0458 |
| SK-BR-3 | R406 | 3.33 | uM | LJP6 | 1.0624 | 0.0407 | 1.0992 | 0.0682 |
| SK-BR-3 | Pictilisib | 3.33 | uM | LJP6 | 0.4001 | 0.0259 | 0.0001 | 0.0745 |
| SK-BR-3 | Gefitinib | 3.33 | uM | LJP6 | 0.5867 | 0.0199 | 0.3100 | 0.0573 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 0.2995 | 0.0335 | -0.1659 | 0.0784 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 0.3045 | 0.0121 | -0.1579 | 0.0584 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 0.2394 | 0.0186 | -0.2693 | 0.0940 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 0.2655 | 0.0235 | -0.2223 | 0.0670 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 1.0030 | 0.0022 | 1.0048 | 0.0034 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 0.2294 | 0.0288 | -0.2864 | 0.1054 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 0.7645 | 0.0176 | 0.6105 | 0.0124 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 0.2911 | 0.0192 | -0.1837 | 0.0932 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 0.3324 | 0.0176 | -0.1096 | 0.0401 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 0.7659 | 0.0469 | 0.6022 | 0.0943 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 1.0570 | 0.0290 | 1.0922 | 0.0482 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 0.3315 | 0.0292 | -0.1105 | 0.0479 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 0.5439 | 0.0200 | 0.2435 | 0.0167 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 0.4004 | 0.0088 | 0.0001 | 0.0649 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 0.3594 | 0.0958 | -0.0504 | 0.1123 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 1.0451 | 0.0358 | 1.0706 | 0.0603 |
| SK-BR-3 | Linsitinib | 3.33 | uM | LJP5 | 0.8052 | 0.0185 | 0.6762 | 0.0319 |